Biogen unveils first spinal muscular atrophy data from Spinraza follow-on
Biogen shared that its next-generation spinal muscular atrophy RNA drug improved measures of neurodegeneration and motor function in an initial cut of data, and the company is planning to move the experimental treatment into Phase ...
Biogen shared that its next-generation spinal muscular atrophy RNA drug improved measures of neurodegeneration and motor function in an initial cut of data, and the company is planning to move the experimental treatment into Phase ...
